SEARCH

SEARCH BY CITATION

References

  • 1
    Taylor CP. Mechanisms of action of new antiepileptic drugs. In: Chadwick, D, ed. New Trends in Epilepsy Management: The Role of Gabapentin. London: Royal Society of Medicine, 1993; 1340.
  • 2
    Satzinger G. Antiepileptics from gamma-aminobutyric acid. Arzneimittelforchung 1994; 44: 2616.
  • 3
    Bartoszyk GD, Meyerson N, Reimann W, Satzinger G, Von Hodenberg G. Gabapentin In: Meldrum, BS, Porter, BJ, eds. New Anticonvulsant Drugs. London: John Libbey, 1986; 14763.
  • 4
    Hooper WD, Kavanagh MC, Dickinson RB. Determination of gabapentin in plasma and urine by capillary column gas chromatography. Journal of Chromatography 1990; 529: 16774.
  • 5
    Hengy H, Kolle EU. Determination of gabapentin in plasma and urine by high-performance liquid chromatography and precolumn labeling for ultraviolet detection. Journal of Chromatography 1985; 341: 4738.
  • 6
    Stewart BH, Kugler AR, Thompson PR, Bockbrader HN. A saturable transport mechanism in the intestinal absorption of gabapentin is the underlying cause of the lack of proportionality between increasing dose and drug levels in plasma. Pharmaceutical Research 1993; 10: 27681.
  • 7
    Vollmer KO, Anhut H, Thomann P, Wagner F, Jahncken D. Pharmacokinetic model and absolute bioavailability of the new anticonvulsant gabapentin. Advances in Epileptology 1989; 17: 20911.
  • 8
    Türck D, Vollmer KO, Bockbrader H, Sedman A. Dose-linearity of the new anticonvulsant gabapentin after multiple oral doses. European Journal of Clinical Pharmacology 1989; 36 (Suppl.): A310.
  • 9
    Richens A. Clinical pharmacokinetics of gabapentin. In: Chadwick, D, ed. New Trends in Epilepsy Management: The Role of Gabapentin. London: Royal Society of Medicine, 1993; 416.
  • 10
    Hooper WD, Kavanagh MC, Dickinson RB, Herkes GK, Eadie MJ. Lack of a pharmacokinetic interaction between phenobarbitone and gabapentin. British Journal of Clinical Pharmacology 1991; 31: 1714.
  • 11
    Vollmer KO, Van Hodenberg AV, Kölle EU. Pharmacokinetics and metabolism of gabapentin in rat, dog and man. Arzneimittel-Forschung/Drug Research 1986; 36: 8309.
  • 12
    Ben-Menachem E, Persson LI, Hedner T. Selected CSF biochemistry and gabapentin concentrations in the CSF and plasma in patients with partial seizures after a single oral dose of gabapentin. Epilepsy Research 1992; 11: 459.
  • 13
    Ojemann LM, Friel PN, Ojemann GA. Gabapentin concentrations in human brain. Abstract. Epilepsia 1988; 29: 694.
  • 14
    Comstock TJ, Sica DA, Bockbrader HN, Underwood BA, Sedman AJ. Gabapentin pharmacokinetics in patients with various degrees of renal function. Journal of Clinical Pharmacology 1990; 30: 862.
  • 15
    Schmidt B. Potential antiepileptic drugs: gabapentin. In: Levy, R, Mattson, R, Meldrum, B, Penry, JK, Dreifuss, FE, eds. Antiepileptic Drug, 3rd edn. New York: Raven Press, 1989; 92535.
  • 16
    Anhut H, Leppik I, Schmidt B, Thomann P. Drug interaction study of the new anticonvulsant gabapentin with phenytoin in epileptic patients. Abstract Naunyn-Schmiedeberg's Archives of Pharmacology 1988; 337 (Suppl.): R127.
  • 17
    Graves NM, Holmes GB, Leppik IE, Rask C, Slavin M, Anhut H. Pharmacokinetics of gabapentin in patients treated with phenytoin. Pharmacotherapy 1989; 9: 196.
  • 18
    Wong MO, Eldon MA, Keane WF, et al. Disposition of gabapentin in anuric subjects on hemodialysis. Journal of Clinical Pharmacology 1995; 35: 6226.
  • 19
    Busch JA, Radulovic LL, Bockbrader HN, Underwood BA, Sedman AJ, Chang T. Effect of Maalox TC on single-dose pharmacokinetics of gabapentin capsules in healthy subjects. Pharmaceutical Research 1992; 9 (Suppl.): S315.
  • 20
    Hill DR, Suman-Chauhan N, Woodruff GN. Localisation of [3H]gabapentin to a novel site in rat brain: autoradiographic studies. European Journal of Pharmacology – Molecular Pharmacology Section 1993; 244: 3039.
  • 21
    Welty DF, Schielke GP, Vartanian MG, Taylor CP. Gabapentin anticonvulsant action in rats: disequilibrium with peak drug concentrations in serum and brain microdialysate. Epilepsy Research 1993; 16: 17581.
  • 22
    Suman-Chauhan N, Webdale N, Hill DR, Woodruff GN. Characterisation of [3H]-gabapentin binding to a novel site in rat brain: homogenate binding studies. European Journal of Pharmacology 1993; 244: 293301.
  • 23
    Taylor CP, Vartanian MG, Yuen P, Bigge C, Suman-Chauhan N, Hill DR. Potent and stereospecific anticonvulsant activity of 3-isobutyl GABA relates to in vitro binding at a novel site labelled by tritiated gabapentin. Epilepsy Research 1993; 14: 1115.
  • 24
    Löscher W, Hönack D, Taylor CP. Gabapentin increases aminooxyacetic acid induced GABA accumulation in several regions of rat brain. Neuroscience Letters 1991; 128: 1504.
  • 25
    Petioff OA, Rothnan DL, Behan KL. The effect of gabapentin on brain gamma-aminobutyric acid in patients with epilepsy. Annals of Neurology 1996; 39: 959.
  • 26
    Reimann W. Inhibition by GABA, baclofen and gabapentin of dopamine release from rabbit caudate nucleus. Are there common or different sites of action? European Journal of Pharmacology 1986; 94: 34144.
  • 27
    Schlicker E, Reimann W, Göthert M. Gabapentin decreases monoamine release without affecting acetylcholine release in the brain. Arzneimittel-Forschung 1985; 35: 1347.
  • 28
    Wamil AW, McLean MJ. Limitation by gabapentin of high frequency action potential firing by mouse central neurons in cell culture. Epilepsy Research 1994; 17: 111.
  • 29
    Abdi S, Lee DH, Chung JM. The anti-allodynic effects of amitryptyline, gabapentin and lidocaine in a rat model of neuropathic pain. Anesthesia and Analgesia 1998; 87: 13606.
  • 30
    Pan HL, Eisenach JC, Chen SR. Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. Journal of Pharmacology and Experimental Therapeutics 1999; 288: 102630.
  • 31
    Field MJ, Oles OJ, Lewis AS, McCleary S, Hughes J, Singh L. Gabapentin (neurontin) and S-(+)-3-isobutyl GABA represent a novel class of selective antihyperalgesic agents. British Journal of Pharmacology 1997; 121: 151322.
  • 32
    Hwang JH, Yaksh TL. Effect of subarachnoid gabapentin on tactile-evoked allodynia in a surgically-induced neuropathic pain model in the rat. Regional Anesthesia 1997; 22: 24956.
  • 33
    Partridge BJ, Chaplan SR, Sakamoto E, Yaksh TL. Characterization of the effects of gabapentin and 3-isobutyl-(-aminobutyric acid) on substance-P induced thermal hyperalgesia. Anesthesiology 1998; 88: 196205.
  • 34
    Yoon MH, Yaksh TL. The effect of intrathecal gabapentin on pain behaviour and hemodynamics on the formalin test in␣the rat. Anesthesia and Analgesia 1999; 89: 4349.
  • 35
    Patel MK, Gonzalez MI, Bramwell S, Pinnock RD, Lee K. Gabapentin inhibits excitatory synaptic transmission in the hyperalgesic spinal cord. British Journal of Pharmacology 2000; 130: 17314.
  • 36
    Jun JH, Yaksh TL. The effect of intrathecal gabapentin a 3-isobutyl gamma-aminobutyric acid on the hyperalgesia observed after thermal injury in the rat. Anesthesia and Analgesia 1998; 86: 34854.
  • 37
    Calton SM, Zhou S. Attenuation of formalin-induced nociceptive behaviours following local peripheral injection of gabapentin. Pain 1998; 76: 2017.
  • 38
    Taylor CP, Gee NS, Su TZ, et al. A summary of mechanistic hypotheses of gabapentin. Epilepsy Research 1998; 29: 23349.
  • 39
    Rock DM, Kelly KM, Macdonald RL. Gabapentin actions on ligand- and voltage-gated responses in cultures rodent neurons. Epilepsy Research 1993; 16: 8998.
  • 40
    Dingledine R, McBain CJ, McNamara JO. Excitatory amino acid receptors in epilepsy. Trends in Pharmacological Science 1990; 11: 3348.
  • 41
    Malmberg AB, Yaksh TL. Voltage-sensitive calcium channels in spinal nociceptive processing. Blockade of N and P type channels inhibits formalin-induced nociception. Journal of Neuroscience 1994; 14: 488290.
  • 42
    Field MJ, Holloman EF, McCleary S, Hughes J, Singh L. Evaluation of gabapentin and S-(+)-3-isobutylgaba in a rat model of postoperative pain. Journal of Pharmacology and Experimental Therapeutics 1997; 282: 12426.
  • 43
    Jones DL, Sorkin LS. Systemic gabapentin and S(+)-3-isobutyl-gamma-aminobutyric acid block secondary hyperalgesia. Brain Research 1998; 810: 939.
  • 44
    Field MJ, McCleary S, Hughes J, Singh L. Gabapentin and pregabolin, but not morphine and amitryptyline, block both static and dynamic components of mechanical allodynia induced by streptozocin in the rat. Pain 1999; 80: 3918.
  • 45
    Fink K, Meder W, Dooley DJ, Gothert M. inhibition of neuronal Ca(2+) influx by gabapentin and subsequent reduction of neurotransmitter release from rat neocortical slices. British Journal of Pharmacology 2000; 130: 9006.
  • 46
    Dooley DJ, Mieske CA, Borosky SA. Inhibition of K(+)-evoked glutamate release from rat neocortical and hippocampal slices by gabapentin. Neuroscience Letters 2000; 280: 10710.
  • 47
    Ramsay RE. Gabapentin toxicity. In: Levy, RH, Mattson, RH, Meldrum, BS, eds. Antiepileptic Drugs, 4th edn. New York: Raven Press, 1995; 85760.
  • 48
    McLean MJ, Morrell MJ, Willmore LJ, et al. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study. Epilepsia 1999; 40: 96572.
  • 49
    Fischer JH, Barr AN, Rogers SL, Fischer PA, Trudeau VL. Lack of serious toxicity following gabapentin overdose. Neurology 1994; 44: 9823.
  • 50
    Verma A, St Clair EW, Radtke RA. A case of sustained massive gabapentin overdose without serious side effects. Therapeutic Drug Monitoring 1999; 21: 61517.DOI: 10.1097/00007691-199912000-00006
  • 51
    Gallay BJ, De Mattos AM, Norman DJ. Reversible acute renal allograft dysfunction due to gabapentin. Transplantation 2000; 70: 2089.
  • 52
    Gonzalez-Sicilia L, Cano A, Serrano M, Hernandez J. Stevens–Johnson syndrome associated with gabapentin. American Journal of Medicine 1998; 105: 455.
  • 53
    Boneva N, Brenner T, Argov Z. Gabapentin␣may␣be␣hazard-ous in myasthenia␣gravis. Muscle␣Nerve 2000;␣23:␣12048.
  • 54
    Korn-Merker E, Borusiak P, Boenigk HE. Gabapentin in childhood epilepsy. A prospective evaluation of efficacy and safety. Epilepsy Research 1999; 38 (27–32): 57.
  • 55
    Leiderman DB. Gabapentin as add-on therapy for refractory partial epilepsy: results of five placebo-controlled trials. Epilepsia 1994; 35: S7486.
  • 56
    Beydoun A. Monotherapy trials with gabapentin for partial epilepsy. Epilepsia 1999; 40 (Suppl. 6): S1316.
  • 57
    Dodrill CB, Arnett JL, Hayes AG, et al. Cognitive abilities and adjustment with gabapentin: results of a multisite study. Epilepsy Research 1999; 35: 10921.DOI: 10.1016/S0920-1211(99)00006-6
  • 58
    Saletu B, Grünberger J, Linzmeyer L. Evaluation of encephalotropic and psychotropic properties of gabapentin in man by pharmaco-EEG and psychometry. International Journal of Clinical Pharmacology, Therapy and Toxicology 1986; 24: 36273.
  • 59
    Bruni J. Gabapentin. Canadian Journal of Neurological Science 1996; 23 (Suppl. 2): S1012.
  • 60
    Laird MA, Gidal BE. Use of gabapentin in the treatment of␣neuropathic pain. Annals of Pharmacotherapy 2000; 34: 8027.
  • 61
    Cesena RM, Calcutt NA. Gabapentin prevents hyperalgesia during the formalin test in diabetic rats. Neuroscience Letters 1999; 262: 1014.
  • 62
    Yoon MH, Yaksh TL. Evaluation of interaction between gabapentin and ibuprofen on the formalin test in rats. Anesthesiology 1999; 91: 100613.
  • 63
    Chen SR, Eisenach JC, McCaslin PP, Pan HL. Synergistic effect between intrathecal non-NMDA antagonist and gabapentin on allodynia induced by spinal nerve ligation in rats. Anesthesiology 2000; 92: 5006.
  • 64
    Rosenberg JM, Harrell C, Ristic H, Werner RA, De Rosayro AM. The effect of gabapentin on neuropathic pain. Clinical Journal of Pain 1997; 13: 2515.DOI: 10.1097/00002508-199709000-00011
  • 65
    Attal N, Brasseur L, Parker F, Chauvin M, Bouhassira D. Effects of gabapentin on the different components of peripheral and central neuropathic pain syndromes: a pilot study. European Journal of Neurology 1998; 40: 191200.
  • 66
    Sist TC, Filadora VA, Miner M, Lema M. Experience with gabapentin for neuropathic pain in the head and neck. Report of ten cases. Regional Anesthesia 1997; 22: 4738.
  • 67
    Ness TJ, Crimaldi JC, McDanal JT. Case report on gabapentin. (Letter). Regional Anesthesia and Pain Medicine 1998; 23: 11011.
  • 68
    Vadivelu N, Berger J. Neuropathic pain after anti-HIV gene therapy successfully treated with gabapentin. Journal of Pain and Symptom Management 1999; 17: 1556.
  • 69
    Schacter SC, Sauter MK. Treatment of central pain with gabapentin: case reports. Journal of Epilepsy 1996; 9: 2236.
  • 70
    Hays H, Woodroffe MA. Using gabapentin to treat neuropathic pain. Canadian Family Physician 1999; 45: 210912.
  • 71
    Backonja M, Beydoun A, Edwards KR, et al. Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial. Journal of the American Medical Association 1998; 280: 18316.
  • 72
    Wiffen P, Collins S, McQuay H, Carrol D, Jadad A, Moore A. Anticonvulsant drugs for acute and chronic pain. Cochrane Database System Review 2000; 3: CD001133.
  • 73
    Perez HET & Sanchez GF. Gabapentin therapy for diabetic neuropathic pain. American Journal of Medicine 2000; 108: 68990.
  • 74
    Morello CM, Leckband SG, Stoner CP, Moorhouse DF, Sahagian GA. Randomised double-blind study comparing the efficacy of gabapentin with amitryptyline on diabetic peripheral neuropathy pain. Archives of Internal Medicine 1999; 159: 19317.
  • 75
    Dallochio C, Buffa C, Mazzarello P, Chiroli S. Gabapentin vs. amitryptyline in painful diabetic neuropathy. An open-label pilot study. Journal of Pain and Symptom Management 2000; 20: 2805.
  • 76
    Rowbotham M, Harden N, Stacey B, Podolnick P, Magnus-Miller L. Gabapentin for the treatment of postherpetic neuralgia: a randomized controlled trial. Journal of the American Medical Association 1998; 280: 183742.
  • 77
    Caraceni A, Zecca E, Martini C, DeConno F. Gabapentin as an adjuvant to opioid analgesia for neuropathic cancer pain. Journal of Pain and Symptom Management 1999; 17: 441.DOI: 10.1016/S0885-3924(99)00033-0
  • 78
    Valzania F, Strafella AP, Nassetti SA, Tropeani A, Tassinari CA. Gabapentin in trigeminal neuralgia. Abstract. Neurology 1998; 50: A379.
  • 79
    Khan OA. Gabapentin relieves trigeminal neuralgia in multiple sclerosis patients. Neurology 1998; 51: 61114.
  • 80
    Solaro C, Messmer Uccelli M, Uccelli A, Leandri M, Mancardi GL. Low-dose gabapentin combined with either lamotrigine or carbemazepine can be useful therapies for trigeminal neuralgia in multiple sclerosis. European Journal of Neurology 2000; 44: 458.
  • 81
    Stenager E, Knudsen L, Jensen K. Acute and chronic pain syndromes in multiple sclerosis. Acta Neurologica Scandinavica 1991; 84: 197200.
  • 82
    Cutter NC, Scott DD, Johnson JC, Whiteneck G. Gabapentin effect on spasticity in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 2000; 81: 1649.
  • 83
    Mueller ME, Gruenthal M, Olson WL, Olson WH. Gabapentin for relief of upper motor neuron symptoms in multiple sclerosis. Archives of Physical Medicine and Rehabilitation 1997; 78: 5214.
  • 84
    Houtchens MK, Richert JR, Sami A, Rose JW. Open label treatment for pain in multiple sclerosis. Multiple Sclerosis 1997; 3: 2503.
  • 85
    Solaro C, Lunardi GL, Capello E, et al. An open label trial of gabapentin treatment of paroxysmal symptoms in multiple sclerosis patients. Neurology 1998; 51: 60911.
  • 86
    Solaro C, Uccelli MM, Guglieri P, Uccelli A, Mancardi GL. Gabapentin is effective in treating nocturnal painful spasms in multiple sclerosis. Multiple Sclerosis 2000; 6: 1923.
  • 87
    Mellick GA, Mellick LB. Reflex sympathetic dystrophy treated with gabapentin. Archives of Physical Medicine and Rehabilitation 1997; 78: 98105.
  • 88
    Waldman SD, Waldman KA. Reflex sympathetic dystrophy. Internal Medicine Magazine 1990; 11: 628.
  • 89
    Mellick GA, Mellick LB. Gabapentin in the management of reflex sympathetic dystrophy. Journal of Pain and Symptom Management 1995; 10: 2656.
  • 90
    Wheeler DS, Vaux KK, Tam DA. Use of gabapentin in the treatment of childhood reflex sympathetic dystrophy. Pediatric Neurology 2000; 22: 2201.
  • 91
    Di Trapani G, Mei D, Marra C, Mazza S, Capuano A. Gabapentin in the prophylaxis of migraine: a double-blind randomized placebo-controlled study. La Clinica Therapeutica 2000; 151: 1458.
  • 92
    Graff-Radford SB. SUNCT syndrome responsive to gabapentin. Cephalalgia 2000; 20: 51517.DOI: 10.1046/j.1468-2982.2000.00065.x
  • 93
    Ahmed F. Chronic cluster headache responding to gabapentin: a case report. Cephalalgia 2000; 20: 2523.
  • 94
    Davidoff G, Roth E, Guarracini M, Sliwa J, Yarkony G. Function limiting dysesthetic pain syndrome among traumatic SCI patients: a cross sectional study. Pain 1987; 29: 3948.
  • 95
    Mercadante S. Gabapentin in spinal cord injury pain. Pain Clinics of America 1998; 10: 2036.
  • 96
    Ness TJ, San Pedro EC, Richards JS, Kezar L, Liu HG, Mountz JM. A case of spinal cord injury-related pain with baseline rCBF brain SPECT imaging and beneficial response to gabapentin. Pain 1998; 78: 13943.
  • 97
    Kapadia NP, Harden N. Gabapentin for chronic pain in spinal cord injury: a case report. Archives of Physical and Medical Rehabilitation 2000; 81: 143941.
  • 98
    Priebe MM, Sherwood AM, Graves DE, Mueller M, Olson WH. Effectiveness of gabapentin in controlling spasticity: a quantitative study. Spinal Cord 1997; 35: 1715.
  • 99
    Gruenthal M, Mueller M, Olson WL, Priebe MM, Sherwood AM, Olson WH. Gabapentin for treatment of spasticity in patients with spinal cord injury. Spinal Cord 1997; 35: 6869.
  • 100
    Gatti A, Jann S, Sandro E, Manuela B. Gabapentin in the treatment of distal symmetric axonopathy in HIV infected patients. Neurology 1998; 50: A216(Absract P04.053).
  • 101
    Newshan G. HIV neuropathy treated with gabapentin (letter). AIDS 1998; 12: 21921.
  • 102
    Smith LA, Allen EV. Erythermalgia (erythromelalgia) of the extremities: a syndrome characterized by redness, heat and pain. American Heart Journal 1938; 16: 17588.
  • 103
    McGraw T, Kosek P. Erythromelalgia pain managed with gabapentin. Anesthesiology 1997; 86: 98890.
  • 104
    Zapp JJ. Postpoliomyelitis pain treated with gabapentin. American Family Physician 1996; 53 (2442): 2445.
  • 105
    Hansen HC. Interstitial cystitis and the potential role of gabapentin. Southern Medical Journal 2000; 93: 23842.
  • 106
    Serrao M, Rossi P, Cardinali P, Valente G, Parisi L, Pierelli F. Gabapentin treatment for muscle cramps: an open-label trial. Clinical Neuropharmacology 2000; 23: 459.
  • 107
    Van Deventer H, Bernard S. Use of gabapentin to treat taxane-induced myalgias. Journal of Clinical Oncology 1999; 17: 4345.
  • 108
    Bandini F, Mazzella L. Gabapentin as treatment for hemifacial spasm. European Journal of Neurology 1999; 42: 4951.
  • 109
    Ben-David B, Friedman M. Gabapentin therapy for vulvodynia. Anesthesia and Analgesia 1999; 89: 145960.
  • 110
    Rozen TD. Relief of anesthesia dolorosa with gabapentin. Headache 1999; 39: 7612.
  • 111
    Otley CC, Siegel DM. Gabapentin for the treatment of dysesthetic pain after reconstructive surgery. Dermatological Surgery 1999; 25: 4878.
  • 112
    Chatterjee CR, Ringold AL. A case report of reduction in␣alcohol craving and protection against alcohol withdrawal by gabapentin. Journal of Clinical Psychiatry 1999; 60:␣617.
  • 113
    Bonnet U, Banger M, Leweke FM, Maschke M, Kowalski T, Gastpar M. Treatment of alcohol withdrawal syndrome with gabapentin. Pharmacopsychiatry 1999; 32: 1079.
  • 114
    Letterman L, Markowitz JS. Gabapentin: a review of published experience in the treatment of bipolar disorder and other psychiatric conditions. Pharmacotherapy 1999; 19: 56572.
  • 115
    Cabras PL, Hardoy MJ, Hardoy MC, Carta MG. Clinical experience with gabapentin in patients with bipolar of schizoaffective disorder: results of an open-label study. Journal of Clinical Psychiatry 1999; 60: 2458.
  • 116
    Bolts SR, Raskind J. Gabapentin and lamotrigine in bipolar disorder. American Journal of Health-System Pharmacy 1999; 56: 193944.
  • 117
    Schaffer CB, Schaffer LC. Open maintenance treatment of bipolar disorder spectrum patients who responded to gabapentin augmentation in the acute phase of treatment. Journal of Affective Disorders 1999; 55: 23740.
  • 118
    Soloski KN, Green C, Maris DE, DeMet EM. Gabapentin as adjunct to standard mood stabilizers in outpatients with mixed bipolar symptomatology. Annals of Clinical Psychiatry 1999; 11: 21722.
  • 119
    Perugi G, Toni C, Ruffolo G, Sartini S, Simonini E, Akiskal H. Clinical experience using adjunctive gabapentin in treatment-resistant bipolar mixed states. Pharmacopsychiatry 1999; 32: 13641.
  • 120
    Brannon N, Labbate L, Huber M. Gabapentin treatment for post-traumatic stress disorder (letter). Canadian Journal of Psychiatry 2000; 45: 84.
  • 121
    Herrmann N, Lanctot K, Myszak M. Effectiveness of gabapentin for the treatment of behavioral disorders in dementia. Journal of Clinical Psychopharmacology 2000; 20: 903.DOI: 10.1097/00004714-200002000-00015
  • 122
    Roane DM, Feinberg TE, Miner CR, Scicutella A, Rosenthal RN. Treatment of dementia-associated agitation with gabapentin. Journal of Neuropsychiatry and Clinical Neurosciences 2000; 12: 403.
  • 123
    Dallocchio C, Buffa C, Mazzarello P. Combination of donepezil and gabapentin for behavioral disorders in Alzheimer's disease. Journal of Clinical Psychiatry 2000; 61:␣64.
  • 124
    McManaman J, Tam DA. Gabapentin for self-injurious behaviour in Lesch–Nyhan syndrome. Pediatric Neurology 1999; 20: 3812.DOI: 10.1016/S0887-8994(98)00166-0
  • 125
    Gironell A, Kulisevsky J, Barbanoj M, Lopez-Villegas D, Hernandez G, Pascual-Sedano B. A randomized placebo controlled comparative trial of gabapentin and propranolol in essential tremor. Archives of Neurology 1999; 56: 47580.
  • 126
    Novelli G, Mediati RD, Casali R, Palermo P. Treatment of ‘restless legs syndrome’ with gabapentin. Pain Clinics of America 2000; 12: 613.
  • 127
    Bueller HA, Bernhard JD, Dubroff LM. Gabapentin treatment for brachioradial pruritis. Journal of European Dermatology and Venereology 1999; 13: 2278.
  • 128
    Kothare SV, Pollack P, Kulberg AG, Ravin PD. Gabapentin treatment in a child with delayed-onset hemichorea/hemiballismus. Pediatric Neurology 2000; 22: 6871.
  • 129
    Collins SL, Moore RA, McQuay DM, Wiffen P. Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review. Journal of Pain and Symptom Management 2000; 20: 44958.DOI: 10.1016/S0885-3924(00)00218-9
  • 130
    McQuay H, Carroll D, Jadad AR, Wiffen P, Moore A. Anticonvulsant drugs for management of chronic pain: a␣systematic review. British Medical Journal 1995; 311: 104752.
  • 131
    McQuay HJ, Tramer M, Nye BA, Carrol D, Wiffen PJ, Moore RA. A systematic review of antidepressants in neuropathic pain. British Medical Journal 1996; 68: 21727.